The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020.

The market was estimated at $642.0 million in 2012 and is poised to grow at a CAGR of 6.2% from 2012 to 2017 to reach $866.8 million by 2017.

The market is valued at an estimated $3,831.6 million in 2013 and is poised to grow at a CAGR of 10.1% from 2013 to 2018, to reach $6,212.7 million by 2018.

The healthcare IT integration platform and tools form the backbone of any successful healthcare information network.

This report provides detailed market analysis of various healthcare IT solutions available in the market, comprising healthcare provider solutions, healthcare payer solutions, and HCIT outsourcing services

This report studies the global hematology instruments and reagents market over the forecast period of 2014 to 2019. The market is expected to reach $3.13 billion by 2019, at CAGR of 5.2% from 2014 to 2019.

This market is valued at an estimated $43,213.6 million in 2013 and is poised to grow at a CAGR of 9.1% from 2013 to 2018, to reach $66,920.5 million by 2018.

The market is segmented based on products, and types of insulin. Based on products, the global human insulin market is segmented into biologics and biobetters, and biosimilars/biogenerics.

The market is estimated at $2.3 billion in 2013 and is poised to grow at a CAGR of 10% from 2013-2018, to reach $3.7 billion by 2018.

The global home healthcare market is expected to reach USD 349.8 Billion by 2020 from USD 227.5 Billion in 2015, at a CAGR of 9.0% during the forecast period.

The U.S. healthcare payer, provider, and pharmaceutical outsourcing markets are valued at $11.1 billion, $6.8 billion, and $65.6 billion, respectively, in the year 2013.

The global mobile healthcare market is estimated at $6,336 million in 2013 and is poised to reach $20,683 million by 2018 at a CAGR of 26.7%.

The market is estimated at $61.60 billion in 2013 and is poised to grow at a CAGR of 6.2% from 2013 to 2018, to reach $83.21 billion by 2018.

This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020.

The global home healthcare market is expected to reach USD 349.8 Billion by 2020 from USD 227.5 Billion in 2015, at a CAGR of 9.0% during the forecast period.

This report studies the global flow cytometry market over the forecast period of 2013-2018. The market is estimated at $2.3 billion in 2013 and is poised to grow at a CAGR of 10% from 2013-2018, to reach $3.7 billion by 2018.

The global workforce management systems market is estimated to be worth $761.7 million by the end of 2014 and is expected to reach $1,453.8 million by 2019, at a CAGR of 13.8% from 2014 to 2019.

The global microbial identification market is estimated at $896.5 million in 2014 and is expected to reach $1,194.1 million by 2019, growing at a CAGR of 5.9% from 2014 to 2019.

The North America weight loss/obesity management market was worth $104 billion in the year 2012 and is expected to reach $139.5 billion by 2017. U.S. is the largest market, followed by Canada.

The “Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2010 - 2020)” analyzes and studies the major market drivers, restraints, and opportunities in the U.S.

This report studies the global medical power supply market over the forecast period of 2012-2017. The market was estimated at $642.0 million in 2012 and is poised to grow at a CAGR of 6.2% from 2012 to 2017 to reach $866.8 million by 2017.

The global isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period.

The report “Leukemia Therapeutics Market (Acute/Chronic Lymphocytic Leukemia & Acute/Chronic Myeloid Leukemia) Pipeline Assessment & Global Market Forecast (2010 - 2020)”.

The “Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2010 - 2020)” analyzes and studies the major market drivers, restraints, and opportunities in the U.S.

The leukemia therapeutics market was valued at $6.3 billion in 2010 and is expected to reach $11.3 billion by 2020 at a CAGR of 3.84% between 2015 and 2020.